Differential disruption of EWS-FLI1 binding by DNA-binding agents

Changmin Chen1, Diane R Wonsey, Madeleine E Lemieux

  • 1Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Plos One
|July 30, 2013
PubMed

Insights

Actinomycin D selectively disrupts EWS-FLI1 binding to DNA in Ewing sarcoma cells. While not therapeutically viable due to narrow concentration windows, this highlights potential for targeted transcription factor disruption.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Ewing sarcoma arises from the EWS-FLI1 fusion oncoprotein, which drives abnormal gene expression.
  • Targeting the EWS-FLI1 oncoprotein is crucial for Ewing sarcoma treatment.

Purpose of the Study:

  • To screen for compounds that disrupt EWS-FLI1 binding to DNA.
  • To investigate the preferential binding disruption of EWS-FLI1 by actinomycin D.

Main Methods:

  • Utilized a homogenous proximity assay to screen for DNA-binding disrupting compounds.
  • Evaluated compound effects on EWS-FLI1 and p53 DNA binding in vitro.
  • Assessed actinomycin D's impact on EWS-FLI1 chromatin binding and gene expression in cell-based assays.

Main Results:

  • Actinomycin D preferentially disrupted EWS-FLI1 DNA binding over p53 binding in vitro.
  • Low concentrations of actinomycin D selectively blocked EWS-FLI1 chromatin binding and downstream gene expression.
  • Higher concentrations of actinomycin D caused global transcriptional repression.

Conclusions:

  • Actinomycin D exhibits preferential disruption of EWS-FLI1 DNA binding at specific concentrations.
  • The narrow therapeutic window limits actinomycin D's direct application but suggests potential for base-preference-driven targeted therapies.
  • Exploiting DNA base preferences could lead to compounds that selectively inhibit specific transcription factor subclasses.

Related Concept Videos

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Single-Strand DNA Binding Proteins01:03

Single-Strand DNA Binding Proteins

For successful DNA replication, the unwinding of double-stranded DNA must be accompanied by stabilization and protection of the separated single strands of the DNA. This crucial task is performed by single-strand DNA-binding (SSB) proteins. They bind to the DNA in a sequence-independent manner, which means that the nitrogenous bases of the DNA need not be present in a specific order for binding of SSB proteins to it. The binding of SSB proteins straightens single-stranded DNA (ssDNA) and makes...